Publications 2015

  1. Bremer HD, Lattwein E, Renneker S, Lilliehöök I, Rönnelid J, Hansson-Hamlin H. Identification of specific antinuclear antibodies in dogs using line immunoassay and enzyme-linked immunosprbent assay. Vet Immunol Immunopathol 168(3-4): 233-241 (2015).
  2. Diecker J, Schlumberger W, McHugh N, Hamann P, Vlag van der J, Berden JH. Reactivity in ELISA with DNA-loaded nucleosomes in patients with proliferative lupus nephritis. Mol Immunol 68: 20-24 (2015).
  3. Gerlach S, Affeldt K, Pototzki L, Krause C, Voigt J, Fraune J, Fechner K. Automated evaluation of Crithidia luciliae based indirect immunofluorescence tests: A novel application of the EUROPattern-Suite technology. J Immunol Res Article 2015:742402. doi: 10.1155/2015/742402 (2015).
  4. Gosink J. Parathyroid hormone, calcitonin and vitamin D testing in calcium and bone metabolic disorders. Medlab Magazine 2 (2015).
  5. Gutiérrez C, Tejedor-Junco MT, González M, Lattwein E, Renneker S. Presence of antibodies but no evidence for circulation of MERS-CoV in dromedaries on the Canary Islands, 2015. Euro Surveill 20(37) doi: 10.2807/1560-7917.ES.2015.20.37.30019 (2015).
  6. Jarius S, Wildemann B, Stöcker W, Moser A, Wandinger KP. Psychotic syndrome associated with anti-Ca/ARHGAP26 and voltage-gated potassium channel antibodies. J Neuroimmunol 286: 79-82 (2015).
  7. Krause C, Ens K, Fechner K, Voigt J, Fraune J, Rohwäder E, Hahn M, Danckwardt M, Feirer C, Barth E, Martinetz T, Stoecker W. EUROPattern-Suite technology for computer-aided immunofluorescence microscopy in autoantibody diagnostics. Lupus 24: 516-529 (2015).
  8. Langenhan J, Mersmann M, Dworschak J, Schmidt E, Probst C, Stöcker W. Track Z (FS): Novel developments in the diagnosis and treatment of autoimmune blistering diseases. Biomed Tech (Berl.) 60 Suppl 1:s407-25 (2015).
  9. Leypoldt F, Höftberger R, Titulaer MJ, Armangue T, Gresa-Arribas N, Jahn H, Rostasy K, Schlumberger W, Meyer T, Wandinger KP, Rosenfeld MR, Graus F, Dalmau J. Investigations on CXCL13 in anti-N-methyl-D-aspartate-receptor encephalitis: a potential biomarker of treatment response. JAMA Neurol 72(2): 180-186 (2015).
  10. Mastroianni-Kirsztajn G, Hornig N, Schlumberger W. Autoantibodies in renal disease – clinical significance and recent developments in serological detection. Front Immunol 11(6): 221 (2015).
  11. Michaels MA, Jendrek ST, Korf T, Nitzsche T, Teegen B, Komorowski L, Derer S, Schröder T, Baer F, Lehnert H, Büning J, Fellerman K, Sina C. Pancreatic autoantibodies against CUZD1 and GP2 are associated with distinct clinical phenotypes of Crohn’s Disease. Inflamm Bowel Dis 21(12): 2864-2872 (2015).
  12. Müller MA, Meyer B, Corman VM, Al-Masri M, Turkestani A, Ritz D, Sieberg A, Aldabbagh S, Bosch B-J, Lattwein E, Alhakeem RF, Assiri AM, Albarrak AM, Al-Shangiti AM, Al-Tawfiq JA. Wikramaratna P, Alrabeeah AA, Drosten C, Memish ZA. Presence of Middle East respiratory syndrome coronavirus antibodies in Saudi Arabia: a nationwide, cross-sectional, serological study. Lancet Infect Dis 15(5): 559-564 (2015).
  13. Muth D, Corman VM, Meyer B, Assiri A, Al-Masri M, Farah M, Steinhagen K, Lattwein E, Al- Tawfiq JA, Albarrak A, Müller MA, Drosten C, Memish ZA. Infectious MERS-Coronavirus excretion and serotype variability based on live virus isolates from patients in Saudi Arabia. J Clin Microbiol 53(9): 2951-2955 (2015).
  14. Papp M, Sipeki N, Tornai T, Altorjay I, Norman GL, Shums Z, Roggenbuck D, Fechner K, Stöcker W, Antal-Szalmas P, Veres G, Lakatos PL. Rediscovery of the anti-pancreatic antibodies and evaluation of their prognostic value in a prospective clinical cohort of Crohn's patients: the importance of specific target antigens (GP2 and CUZD1). J Crohns Colitis 9(8): 659-68 (2015).
  15. Piepgras J, Höltje M, Michel K, Li Qin, Otto C, Drenckhahn C, Probst C, Schemann M, Jarius S, Stöcker W, Balint B, Meinck H-M, Buchert R, Dalmau J, Ahnert-Hilger G, Ruprecht K. Anti-DPPX encephalitis: pathogenic effects of antibodies on gut and brain neurons. Neurology 85(10): 890-897 (2015).
  16. Probst C, Komorowski L, Graaff de E, Coevorden-Hameete van M, Rogemond V, Honnorat J, Sabeter L, Graus F, Jarius S, Voltz R, Wildemann B, Franciotta D, Blöcker IM, Schlumberger W, Stöcker W, Sillevis Smitt PAE. Standardized test for anti-tr/DNER in patients with paraneoplastic cerebellar degeneration. Neurol Neuroimmunol Neuroinflamm 2(2):e68 (2015).
  17. Rohwäder E, Locke M, Fraune J, Fechner K. Diagnostic profile on the IFA 40: HEp-20-10 – an immunofluorescence test for reliable antinuclear antibody screening. Expert Rev Mol Diagn 15(4):451-62 (2015).
  18. Reichert S, Schlumberger W, Dähnrich C, Hornig N, Altermann W, Schaller HG, Schulz S. Association of levels of antibodies against citrullinated cyclic peptides and citrullinated a-enolase in chronic and aggressive periodontitis as a risk factor of rheumatoid arthritis: a case control study. J Trans Med 132(83):1-10 (2015).
  19. Scharf M, Miske R, Heidenreich F, Giess R, Landwehr P, Blöcker M, Begemann N, Denno Y, Tiede S, Dähnrich C, Schlumberger W, Unger M, Teegen B, Stöcker W, Probst C, Komorowski L. Neuronal Na(+)/K(+) ATPase is an autoantibody target in paraneoplastic neurological syndrome. Neurology 84(16): 1673-1679 (2015).
  20. Schlumberger W. Autoantibody diagnostics in autoimmune nephropathies. Medlab Magazine 2 (2015).
  21. Seitz-Polski B, Dolla G, Payré C, Tomas NM, Lochouarn M, Jeammet L, Mariat C, Krummel T, Burtey S, Courivaud C, Schlumberger W, Zorzi K, Benzaken S, Bernard G, Esnault VL, Lambeau G. Cross-reactivity on anti-PLA2R1 autoantibodies to rabbit and mouse PLA2R1 antigens and development of two novel ELISAs with different diagnostic performances in idiopathic membranous nephropathy. Biochimie 118: 104-115 (2015).
  22. Stoeck K, Carstens P-O, Jarius S, Raddatz D, Stöcker W, Wildemann B, Schmidt J. Prednisolone and azathioprine are effective in DPPX antibody-positive autoimmune encephalitis with glucocorticosteroids and azathioprine. Neurol Neuroimmunol Neuroinflamm 2(3):e86 (2015).
  23. Sutphen CL, Jasielec MS, Shah AR, Macy EM, Xiong C, Vlassenko AG, Benzinger TLS, Stoops EEJ, Vanderstichele HMJ, Brix B, Darby HA, Vandijck MLJ, Ladenson JH, Morris JC, Holtzman DM, Fagan AM. Longitudinal cerebrospinal fluid biomarker changes in preclinical Alzheimer’s disease during middle age. JAMA Neurol 72(9):1029-1042 (2015).
  24. Zerche M, Weissenborn K, Ott C, Dere E, Asif AR, Worthmann H, Hassouna I, Rentzsch K, Tryc AB, Dahm L, Steiner J, Binder L, Wiltfang J, Sirén A, Stöcker W, Ehrenreich H. Pre-existing serum autoantibodies against the NMDAR subunit NR1 modulate evolution of lesion size in acute ischemic stroke. Stroke 46(5):1180-1186 (2015).
  1. Brix B, Vanderstichele H. Use of Beta-Amyloid 1-42/1-40 Ratio in routine diagnostic labs. 11. International Conference on Alzheimer’s and Parkinson’s Disease, Nice, France (2015).
  2. Cavalar M, Harder M, Hellberg L, Opelka P, Götzl J, Steller U. HPV detection and typing by molecular diagnostic microarray. EUROGIN, Seville, Spain (2015).
  3. Dähnrich C, van Beek N, Hornig N, Goletz S, Dworschak J, Schlumberger W, Zillikens D, Schmidt E. Multivarianter Profil-ELISA zur sensitiven und spezifischen Einschrittdiagnostik bullöser Autoimmundermatosen. 48. DDG Tagung, Berlin, Germany (2015).
  4. Edmonson DG, Witt B, Probst C, Schlumberger W, Stöcker W, Norris SJ, Komorowski L. Passive immunization using polyclonal or monoclonal anti-dimeric OspC antibodies prevents infection with Borrelia burgdorferi B31 in mice. 14. ICLB, Vienna, Austria (2015).
  5. Gerlach S, Affeldt K, Pototzki L, Krause C, Voigt J, Fraune J, Stöcker W, Fechner K. Automated evaluation of Crithidia luciliae IFT as novel application of the “EUROPattern-Suite”. 12. Dresden Symposium on Autoantibodies, Dresden, Germany (2015).
  6. Gerlach S, Hochstrate N, Affeldt K, Viertel V, Krause C, Voigt J, Fraune J, Stöcker W, Fechner K. Automated immunofluorescence microscopy for instant screening and confirmation of ANCA. 12. Dresden Symposium on Autoantibodies, Dresden, Germany (2015).
  7. Kaden J, Herbst V, Block M, Scherberich J, Abendroth D, Nockher A, Schlumberger W. Uromodulin serum levels in kidney graft donors and recipients. 24. Annual Meeting of the German Transplantation Society, Dresden, Germany (2015).
  8. Kaden J, Herbst V, Block M, Schlumberger W. Serum uromodulin level and early kidney graft function. 17. Congress of the European Society for Organ Transplantation, Brussels, Belgium (2015).
  9. Komorowski L, Scharf M, Teegen B, Rentzsch K, Schlumberger W, Stöcker W. Autoantibodies against tubular basement membrane in progressive systemic sclerosis are directed against Scl-70. 12. Dresden Symposium on Autoantibodies, Dresden, Germany (2015).
  10. Miske R, Rosenkranz T, Müller M, Hahn S, Blöcker IM, Mindorf S, Denno Y, Schlumberger W, Stöcker W, Probst C, Terborg C, Komorowski L. Autoantibodies against glutamate receptor delta2 in a Caucasian patient after allogenic stem cell transplantation. 1. Congress of the European Academy of Neurology, EAN, Berlin, Germany (2015).
  11. Miske R, Melzer N, Scharf M, Wiendl H, Meuth S, Synofzik M, Dettmann IM, Mindorf S, Denno Y, Teegen B, Stöcker W, Brakopp S, Probst C, Komorowski L. Neurochondrin is a target for autoantibodies in a unique form of autoimmune cerebellitis associated with brainstem syndrome. 12. Dresden Symposium on Autoantibodies, Dresden, Germany (2015).
  12. Seismann H, Bantleon F, Wolf S, Weimann A, Suer W, Jakob T, Bilo B, Spillner E. Component resolution for improved diagnostics of hymenoptera venom allergy using a set of recombinant vespula and polistes venom allergens. European Academy of Allergy and Clinical Immunology Congress 2015, EAACI, Barcelona, Spain (2015).
  13. Stöcker W, Probst C, Teegen B, Rentzsch K, Schlumberger W, Fraune J, Komorowski L. Multiparameter autoantibody screening in the diagnosis of neurological autoimmune diseases. 1. Congress of the European Academy of Neurology, EAN, Berlin, Berlin (2015).
  14. Ullmann AJ, Brandt KS, Zachary PW, Dolan MC, Gilmore R, Witt B, Stöcker W, Schlumberger W, Probst C, Komorowski L. N-terminally disulfide-bridged dimeric OspC is a promising candidate for a practical Lyme vaccine. 14. ICLB, Vienna, Austria (2015).
  1. Heick SB. Cutting-edge molecular diagnostics of genetic and infectious diseases. 8. International & 13. National Congress on Quality Improvement in Clinical Laboratories, Tehran, Iran (2015).
  2. Komorowski L. Neurochondrin is a target for autoantibodies in a unique form of autoimmune cerebellitis associated with brainstem syndrome. 12. Dresden Symposium on Autoantibodies, Dresden, Germany (2015).
  3. Schlumberger W. Algorithm of coeliac disease investigation. 40. Arab Health Congress/ Medlab, Dubai, United Arab Emirates (2015).
  4. Schlumberger W. Novel markers in autoimmunity: Kidney and neurological diseases. 40. Arab Health Congress/ Medlab, Dubai, United Arab Emirates (2015).
  5. Schlumberger W. Autoantibodies against phospholipase-A2 receptors in membranous nephropathy. Seminar, Unità Operativa Complessa di Nefrologia, Università Cattolica, Rome, Italy (2015).
  6. Stöcker W. Comprehensive diagnostics of neurology-related autoantibodies using authentic recombinant autoantigens. All-Russia XX Conference on Neuroimmunolgy, Multiple Sclerosis, St. Petersburg, Russia (2015).
  7. Stöcker W. Discovery of new target antigens in autoimmune encephalitis applying histoimmune precipitation. EUROIMMUN Autoimmunity Tripartite Forum 2015 (Tripartite: Clinic, Laboratory, and EUROIMMUN), Peking, China (2015).
  8. Stöcker W. Revealing new forms of autoimmune encephalitis associated with autoantibodies against neuron specific Na/K-ATPase ATP1A3, neurochondrin, flotillin and inositoltriphosphat-receptors. Peking Union Medical College Hospital, Peking, China (2015).
  9. Stöcker W. Discovery of new target antigens in autoimmune encephalitis applying histoimmune precipitation. 12. Dresden Symposium on Autoantibodies, Dresden, Germany (2015).
  1. Antonini A, Lanzillotta A, Pizzi M, Spano P. An in vitro method of diagnosing parkinson's disease. International patent application WO 2015/110261 (filed 2015).
  2. EUROIMMUN China. Vorrichtung zur biologischen Detektion. German utility patent application DE 20 2015 001 876 (filed 2015).
  3. EUROIMMUN China. Western Blot-Analysiervorrichtung. German utility patent application DE 20 2015 001 878 (filed 2015).
  4. Feirer C, Pannhoff H. Kalibriernormal für eine Vorrichtung zur bildlichen Darstellung biologischen Materials. German and International patent application DE 10 2013 021 097 (filed 2013) and WO 2015/90534 (filed 2014).
  5. Hüttmann G, Morrin M, Spahr H. Verfahren zum Abbilden eines Objektes und Optikvorrichtung. German and International patent application DE 10 2014 002 584 (filed 2014) and WO 2015/110250 (filed 2015).
  6. Komorowski L, Scharf M, Miske R, Denno Y, Dettmann IM, Probst C, Heidenreich F, Gieß R. Diagnosis of neurological disease. US patent application US 2015/0355177A1 (filed 2015).
  7. Meyer W, Scheper T, Kaffka R. Method for automated evaluation of incubated immunoblot strips. Chinese patent application CN105143856A (filed 2014).
  8. Rottmann N, Stöcker W. Verfahren und Analysevorrichtung zur mikroskopischen Untersuchung eines Gewebeschnittes oder eines Zellausstrichs. European and US patent application EP 2 872 254 (filed 2013) and US 2015/211964 (filed 2013).
  9. Rottmann N, Stöcker W. Transparenter Objektträger mit Kennzeichnung. European and International patent application EP 2 896 458 (filed 2014) and WO 2015/106774 (filed 2014).
  10. Scharf M, Dettmann IM, Komorowski L, Miske R, Probst C, Denno Y, Heidenreich F, Gieß R. Diagnosis of neurological disease. European patent application EP 2 952 898
    (filed 2014).
  11. Stöcker W. Verbesserte Vorrichtung und Verfahren für Reaktionen zwischen einer festen und einer flüssigen Phase. German and International patent application DE 10 2014 001 481 (filed 2014) und WO 2015/62715 (filed 2014).
  12. Stöcker W, Kowtun A, Maltzahn B, Koschinat L, Richter L. Verfahren und Vorrichtung zur Überführung von Flüssigkeiten. European and International patent application EP 2 959 971 (filed 2014) and WO 2015/197176 (filed 2015).